Cobalis Corp. (fka CLSC)

[qawpol]

This is basically a failed trial. I am reading all these posts that are simply speculations and guesses based on little or no fact. We know that the "data is corrupted" Since many of you are self proclaimed biotech investing experts, how often have you seen a pivotal trial like this produce acceptable data for approval when there is apparently problems with the data?

If you guys are holding out hope that somehow in a few weeks all will come out well than you need psychiatric help. We passed that point about a month ago. The results were delayed because they were trying to make it work and couldn't. Now this is a desperation attempt to salvage "some" data.

Mark my words: this drug will not get approved on this data. They will most likely need to rerun a phase III and secure financing. 0.50 is a fair price for foreseeable future until we know more. Additionally, this stock may be worth a lot less if they can't get this figured out..... 0.50 sale of stock today + tax loss write off is not the end of the world.